VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3264
ETF rank
A$19.45 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
A$29.48
Share price
-1.12%
Change (1 day)
-2.57%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of June 2026: 0.35%